Literature DB >> 33568632

The docking of synaptic vesicles on the presynaptic membrane induced by α-synuclein is modulated by lipid composition.

Wing K Man1, Bogachan Tahirbegi2, Michail D Vrettas3, Swapan Preet1, Liming Ying4, Michele Vendruscolo1, Alfonso De Simone5,6, Giuliana Fusco7.   

Abstract

α-Synuclein (αS) is a presynaptic disordered protein whose aberrant aggregation is associated with Parkinson's disease. The functional role of αS is still debated, although it has been involved in the regulation of neurotransmitter release via the interaction with synaptic vesicles (SVs). We report here a detailed characterisation of the conformational properties of αS bound to the inner and outer leaflets of the presynaptic plasma membrane (PM), using small unilamellar vesicles. Our results suggest that αS preferentially binds the inner PM leaflet. On the basis of these studies we characterise in vitro a mechanism by which αS stabilises, in a concentration-dependent manner, the docking of SVs on the PM by establishing a dynamic link between the two membranes. The study then provides evidence that changes in the lipid composition of the PM, typically associated with neurodegenerative diseases, alter the modes of binding of αS, specifically in a segment of the sequence overlapping with the non-amyloid component region. Taken together, these results reveal how lipid composition modulates the interaction of αS with the PM and underlie its functional and pathological behaviours in vitro.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33568632      PMCID: PMC7876145          DOI: 10.1038/s41467-021-21027-4

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  83 in total

1.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

Authors:  J M George; H Jin; W S Woods; D F Clayton
Journal:  Neuron       Date:  1995-08       Impact factor: 17.173

2.  Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.

Authors:  Kelvin C Luk; Victoria Kehm; Jenna Carroll; Bin Zhang; Patrick O'Brien; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2012-11-16       Impact factor: 47.728

3.  Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons.

Authors:  D D Murphy; S M Rueter; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

Review 4.  Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Annu Rev Biochem       Date:  2017-05-12       Impact factor: 23.643

Review 5.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

Review 6.  Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.

Authors:  Vladimir N Uversky; David Eliezer
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

7.  α-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

8.  Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers.

Authors:  Giuliana Fusco; Serene W Chen; Philip T F Williamson; Roberta Cascella; Michele Perni; James A Jarvis; Cristina Cecchi; Michele Vendruscolo; Fabrizio Chiti; Nunilo Cremades; Liming Ying; Christopher M Dobson; Alfonso De Simone
Journal:  Science       Date:  2017-12-15       Impact factor: 47.728

9.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

Review 10.  The Synaptic Function of α-Synuclein.

Authors:  Jacqueline Burré
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

View more
  16 in total

1.  α-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes.

Authors:  Aysegul Dilsizoglu Senol; Maura Samarani; Sylvie Syan; Carlos M Guardia; Takashi Nonaka; Nalan Liv; Patricia Latour-Lambert; Masato Hasegawa; Judith Klumperman; Juan S Bonifacino; Chiara Zurzolo
Journal:  PLoS Biol       Date:  2021-07-20       Impact factor: 8.029

2.  Lipid Species Dependent Vesicles Clustering Caused by alpha-Synuclein as Revealed by Single-Vesicle Imaging with Total Internal Reflection Fluorescence Microscopy.

Authors:  Chinta Mani Aryal; Owen Tyoe; Jiajie Diao
Journal:  Biophys Rep       Date:  2021-12

Review 3.  Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases.

Authors:  Orkid Coskuner-Weber; Ozan Mirzanli; Vladimir N Uversky
Journal:  Biophys Rev       Date:  2022-06-08

4.  Glycation of α-synuclein hampers its binding to synaptic-like vesicles and its driving effect on their fusion.

Authors:  Ana Belén Uceda; Juan Frau; Bartolomé Vilanova; Miquel Adrover
Journal:  Cell Mol Life Sci       Date:  2022-06-04       Impact factor: 9.207

5.  Plasticity of Membrane Binding by the Central Region of α-Synuclein.

Authors:  Carlos Navarro-Paya; Maximo Sanz-Hernandez; Alfonso De Simone
Journal:  Front Mol Biosci       Date:  2022-06-15

6.  Aromaticity at position 39 in α-synuclein: A modulator of amyloid fibril assembly and membrane-bound conformations.

Authors:  Fiamma A Buratti; Nicola Boeffinger; Hugo A Garro; Jesica S Flores; Francisco J Hita; Phelippe do Carmo Gonçalves; Federico Dos Reis Copello; Leonardo Lizarraga; Giulia Rossetti; Paolo Carloni; Markus Zweckstetter; Tiago F Outeiro; Stefan Eimer; Christian Griesinger; Claudio O Fernández
Journal:  Protein Sci       Date:  2022-07       Impact factor: 6.993

7.  Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a Drosophila model of Parkinson's disease.

Authors:  Victor Girard; Florence Jollivet; Oskar Knittelfelder; Marion Celle; Jean-Noel Arsac; Gilles Chatelain; Daan M Van den Brink; Thierry Baron; Andrej Shevchenko; Ronald P Kühnlein; Nathalie Davoust; Bertrand Mollereau
Journal:  PLoS Genet       Date:  2021-11-17       Impact factor: 5.917

8.  The Stimulatory Effects of Intracellular α-Synuclein on Synaptic Transmission Are Attenuated by 2-Octahydroisoquinolin-2(1H)-ylethanamine.

Authors:  Alejandra E Ramirez; Eduardo J Fernández-Pérez; Nicol Olivos; Carlos F Burgos; Subramanian Boopathi; Lorena Armijo-Weingart; Carla R Pacheco; Wendy González; Luis G Aguayo
Journal:  Int J Mol Sci       Date:  2021-12-09       Impact factor: 5.923

Review 9.  Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.

Authors:  Nelson de Oliveira Manzanza; Lucia Sedlackova; Raj N Kalaria
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

10.  Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson's disease.

Authors:  Luis Fonseca-Ornelas; Thibault Viennet; Matteo Rovere; Haiyang Jiang; Lei Liu; Silke Nuber; Maria Ericsson; Haribabu Arthanari; Dennis J Selkoe
Journal:  Cell Rep       Date:  2021-07-06       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.